Agnès P.
- Country
- France
- Department
- Centre expert Troubles bipolaires
Research Overview
- Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Duvakitug for Induction Therapy in Moderately to Severely Active Crohn's Disease
- One-Year Real-World Effectiveness of Subcutaneous Guselkumab in Adults with Crohn’s Disease
- Phase 3b, Randomized, Open‑Label, Active‑Controlled Trial Comparing Guselkumab Versus Risankizumab for Efficacy and Safety in Moderately to Severely Active Crohn’s Disease
Data & Insights
Has run more than one trial at 156 of 265 partner sites.
Specializations
Inflammatory Bowel Disease Management
The investigator specializes in treating complex inflammatory bowel conditions, with particular emphasis on Crohn's disease and ulcerative colitis.
- Moderate to Severe Crohn's Disease
- Perianal Fistulizing Disease
- Ulcerative Colitis
Their clinical focus includes innovative therapeutic approaches for managing inflammatory bowel conditions.
Advanced Therapeutic Applications
The investigator works with novel biologic therapies including targeted treatments such as guselkumab and ustekinumab for inflammatory conditions.
- Subcutaneous Therapeutic Administration
- Biological Response Monitoring
- Clinical Remission Assessment
Their work encompasses the evaluation of therapeutic responses in gastrointestinal disorders.
Clinical Assessment Expertise
The investigator focuses on endoscopic evaluation and monitoring of therapeutic efficacy in inflammatory bowel conditions.
- Disease Activity Assessment
- Endoscopic Response Evaluation
- Clinical Response Monitoring
Their expertise includes comprehensive assessment of treatment outcomes in gastrointestinal disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.